Wikidata

(Q62817773)

English

Towards Personalized Dosing of Natalizumab in Multiple Sclerosis

clinical trial

In more languages

Statements

short name
PDNMS (English)
0 references
title
Towards Personalized Dosing of Natalizumab in Multiple Sclerosis (English)
0 references
medical condition
sclerosis
0 references
multiple sclerosis
0 references
country
Netherlands
0 references
start time
3 November 2016
0 references
end time
June 2019
0 references
number of participants
60
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62817773&oldid=1857081034"